Opexa Therapeutics, Inc. OPXA today announced the
conversion of the Company's outstanding 12% convertible secured
promissory notes into shares of common stock. Notes in the aggregate
principal amount of $3.185 million plus accrued interest were converted
into an aggregate of 1,714,697 shares of Opexa common stock on September
24, 2013 at a conversion price of $1.91, which represented the most
recent closing market price of Opexa's common stock at the time of
conversion. Opexa intends to file a Form S-3 registration statement with
the Securities and Exchange Commission to register the common stock.
The conversion of the
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in